November 18, 2026 · American heart journal · DOI: 10.1016/j.ahj.2026.107658

Left Atrial Appendage Closure Versus DOAC Therapy in Atrial Fibrillation: A Phenotype-Centered Systematic Review and Meta-analysis of Randomized Trials.

Listen to this summary

This meta-analysis of five randomized trials (n = 6,239) asked whether left atrial appendage closure (LAAC) is a viable alternative to direct oral anticoagulants (DOACs) for patients with non-valvular high-risk atrial fibrillation. LAAC showed no significant difference in mortality or stroke compared with DOACs, but it was associated with less nonprocedural clinically relevant bleeding and more systemic thromboembolism, pericardial effusion, and serious adverse events. The authors conclude that LAAC should be selected for specific patient phenotypes rather than routinely substituted for anticoagulation.

Ayush Kumar, Muhammad Arham, Priya Kumar, Zahra Ali, Kartikeya Srivastava, Haris Bin Tahir, Hamza Hameed, Manahil Shafique, Fnu Kainat, Hassan Waqar, Sooraj Kumar, Ali Bin Abdul Jabbar, Mario Garcia, James A Mann, Richard C Becker

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play